Insider Transactions in Q1 2024 at Olema Pharmaceuticals, Inc. (OLMA)
Insider Transaction List (Q1 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 28
2024
|
Cyrus Harmon |
SELL
Open market or private sale
|
Direct |
20,000
-2.36%
|
$200,000
$10.97 P/Share
|
|
Mar 18
2024
|
Naseem Zojwalla CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
13,700
+14.56%
|
$54,800
$4.87 P/Share
|
|
Mar 05
2024
|
Andrew Rappaport |
BUY
Other acquisition or disposition
|
Indirect |
385,965
+50.0%
|
-
|
|
Mar 05
2024
|
Andrew Rappaport |
SELL
Other acquisition or disposition
|
Indirect |
481,014
-100.0%
|
-
|
|
Feb 29
2024
|
Cyrus Harmon |
SELL
Open market or private sale
|
Direct |
25,000
-1.43%
|
$300,000
$12.71 P/Share
|
|
Feb 01
2024
|
Cyrus Harmon |
SELL
Open market or private sale
|
Direct |
5,000
-0.57%
|
$75,000
$15.56 P/Share
|
|
Jan 31
2024
|
Cyrus Harmon |
SELL
Open market or private sale
|
Direct |
25,000
-2.77%
|
$300,000
$12.23 P/Share
|
|
Jan 25
2024
|
Naseem Zojwalla CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+23.08%
|
$140,000
$7.02 P/Share
|
|
Jan 12
2024
|
Shane William Charles Kovacs Ch. Operating & Financial Off. |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+9.35%
|
$350,000
$7.02 P/Share
|